Submitted by usatoday9336 in business
The money will be split by small biotech companies that might struggle to pay for clinical trials comparing new vaccines against those now available.
Submitted by usatoday9336 in business
The money will be split by small biotech companies that might struggle to pay for clinical trials comparing new vaccines against those now available.